Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR2 | P50052 | 11/20 | 0.75 |
| ▸ | AGTR1 | P30556 | 4/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31332118 | 0.98 | AGTR2 (0.71) | AGTR2AGTR1 | |
| Angiotensin Ii SCHEMBL29361852 | 0.86 | AGTR2 (1.00) | AGTR2AGTR1 | |
| SCHEMBL29394721 | 0.86 | AGTR2 (1.00) | AGTR2AGTR1 | |
| Angiotensin Ii SCHEMBL21811603 | 0.86 | AGTR2 (1.00) | AGTR2AGTR1 | |
| Angiotensin Ii SCHEMBL1650427 | 0.86 | AGTR2 (1.00) | AGTR2AGTR1 | |
| Angiotensin Amide SCHEMBL4448793 | 0.85 | AGTR2 (0.63) | AGTR2AGTR1 | |
| Angiotensin Ii SCHEMBL31477824 | 0.85 | AGTR2 (0.98) | AGTR2AGTR1 | |
| SCHEMBL29599255 | 0.85 | AGTR2 (0.90) | AGTR2AGTR1 | |
| Acetic Acid SCHEMBL34470176 | 0.84 | AGTR2 (0.83) | AGTR2AGTR1 | |
| SCHEMBL29619824 | 0.84 | AGTR2 (0.94) | AGTR2AGTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC. | 2024-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | SCTR, GIPR, APLNR | AGTR2 100/4885AGTR1 51/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.